RxRadio

Mount Everest Insurance Scam: Poisoning claims grabbed attention, but the larger story is a massive alleged insurance fraud scheme tied to Nepal’s Everest region.

Nepal has charged 32 people in connection with a fake helicopter rescue racket that allegedly billed international insurers nearly $20 million between 2022 and 2025.

According to investigators and reporting on the case:
- more than 300 fake rescues were identified
- 4,782 international climbers were affected
- forged medical records and inflated billing were central to the scheme
- hospitals, helicopter operators, trekking agencies, and guides were all implicated

Early reports alleged trekkers were deliberately made sick to justify evacuation, including claims involving baking soda in food and misuse of acetazolamide. But Nepal’s CIB later said it found no evidence of deliberate poisoning, and the charge sheet centers on organized fraud rather than poisoning charges.

Read more: https://www.rxradio.fm/news/everest-insurance-scam-alleged-poisoning-fraud

The FDA just approved the first true generic Flovent HFA inhaler, potentially reshaping access and pricing for millions of asthma patients. Read more:

FDA Approves First True Generic Flovent HFA for Asthma Treatment The FDA has approved the first generic version of Flovent HFA (fluticasone propionate) inhaler for asthma. Here's what healthcare providers need to know.

NCPA launches multi-million dollar national ad campaign highlighting personalized care at independent pharmacies. It'll run on national television networks like CNN, Fox News, HGTV, and TLC, as well as social and streaming platforms. Full details:

NCPA Launches National Ad Campaign Promoting Independent Pharmacies NCPA's new multi-million-dollar campaign highlights the personalized care of independent pharmacies over chain and mail-order services.

NEW: Eli Lilly launches Zepbound KwikPen, a single device delivering a full month of tirzepatide therapy.

Lilly Launches Zepbound KwikPen: A Multi-Dose Monthly Option for Weight Management Eli Lilly launches Zepbound KwikPen, a multi-dose device delivering a full month of tirzepatide. Here's what pharmacists need to know about access and pricing.